Interní Med. 2016; 18(1): 36-37 | DOI: 10.36290/int.2016.009

Management of hypertension with fixed-dose triple-combination treatment improves compliance and disease control

MUDr. Jiří Pudich
Kardiovaskulární oddělení Fakultní nemocnice Ostrava

Arterial hypertension, along with smoking, diabetes, dyslipidaemia, and obesity, is among the most significant risk factors of cardiovascular diseases. In the Czech Republic, the prevalence of hypertension in the adult population (25–64 years old) hovers around 35%, with an increase in older age groups. Achievement of target blood pressure levels in hypertensive patients is unsatisfactory and is around 30% in the Czech Republic. The use of fixed-dose triple-combination of perindopril/indapamide/ amlodipine aids in modifying the most significant factors of poor hypertension control, i.e. inadequate patient compliance and underuse of combination treatment by physicians.

Keywords: hypertension, fixed-dose triple-combination, combination treatment in hypertension

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pudich J. Management of hypertension with fixed-dose triple-combination treatment improves compliance and disease control. Interní Med. 2016;18(1):36-37. doi: 10.36290/int.2016.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Špinar J, Špinarová L, Vítovec J. Studie PIANIST - trojkombinace v léčbě hypertenze. Hypertenze & kardiovaskulární prevence 2015; 4(1).
    2. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for management of arterial hypertension. J Hypertension 2013; 31: 1281-1357. Go to original source... Go to PubMed...
    3. Egan BM, Zhayo Y, Axon RN, et al. Uncontrolled and apparent treatment resistant hypertension in the United States, 1998 to 2008. Circulation 2011; 124(9): 1046-1058. Go to original source...
    4. Bramlage P, Böhm M, Volpe M, et al. A global perspective on blood pressure treatment and control in a refferd cohort of hypertensive patients. J Clin Hypertension 2010; 12(9): 666-677. Go to original source...
    5. Václavík J. Kombinační léčba jednou tabletou - budoucnost léčby hypertenze? Interní medicína pro praxi 2014; 16(6).
    6. Widimský J jr, et al. Arteriální hypertenze - současné klinické trendy III. Praha, Triton XIII, 2015: 192 s.
    7. Medical Tribune 2014; 10(22): Přichází první fixní trojkombinace antihypertenziv.
    8. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dosed combinations improve medication compliance: a metanalysis. Am J Med. 2007; 120(8): 713-719. Go to original source... Go to PubMed...
    9. Vítovec J, Špinar J. Kombinovaná léčba hypertenze s přihlédnutím k fixním kombinacím. Kardiologická revue 2014; 16(6): 71-74.
    10. Yamout H, Bakris G. Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus. Hypertension 2014; 63: 220-221. Go to original source...
    11. Chalmer J, Hisatomi A, Woodward M, et al. effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial. Hypertension 2014; 63: 259-264. Go to original source...
    12. Václavík J. Obtížně léčitelná hypertenze. Praha, Mladá fronta a.s., 2015: 134 s.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.